Source: Annual Congress 2012 - Novel approaches to lung transplantation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Cova, M. Colombo, M. Morosini, S. Miserere, S. Inghilleri, S. Magni, D. Prosperi, F. Meloni (Pavia, Milan, Italy). LATE-BREAKING ABSTRACT: Mesenchymal cells isolated from the airways of BOS patients as targets of innovative drug-loaded nanoparticles. Eur Respir J 2012; 40: Suppl. 56, 1854

Member's Comments

No comment yet.

Related content which might interest you: Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Engineered gold nanoparticles targeted to mesenchymal cells from BOS patients can be safely administered to normal mice by inhalation Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD Year: 2015 Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells Source: ERJ Open Res, 5 (2) 00161-2018; 10.1183/23120541.00161-2018 Year: 2019 Aerosolised delivery of mesenchymal stromal cells to the lungs: towards a novel therapy Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017 LATE-BREAKING ABSTRACT: Autophagic induction by graphene oxide and its reductives in pulmonary epithelial cells Source: Annual Congress 2013 –New molecular and cell biology mechanisms Year: 2013 Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Mesenchymal stromal cells and macrophages in sepsis: new insights Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018 Year: 2018 Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 Mesenchymal stem cells and their potential for clinical use Source: Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung Year: 2004 Cell-derived microparticles and the lung Source: Eur Respir Rev 2016; 25: 266-277 Year: 2016 Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Mesenchymal stromal cells in clinical trials: implications for emphysema Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions Year: 2017 LATE-BREAKING ABSTRACT: Anti-fibrotic effects of nintedanib and pirfenidone in 2D versus 3D lung cultures Source: International Congress 2016 – IPF pathogenesis Year: 2016 Imaging of the interaction of fine particles and nanoparticles with lung cells Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see! Year: 2009 LATE-BREAKING ABSTRACT: Tissue-resident epithelial stem/progenitor cells in pulmonary epithelial repair Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015